CYCC – cyclacel pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership [Yahoo! Finance]
Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Form SC 14F1 Cyclacel Pharmaceuticals Filed by: Cyclacel Pharmaceuticals, Inc.
Form SCHEDULE 13D Cyclacel Pharmaceuticals Filed by: Doris Wong Sing Ee
Form 4 Cyclacel Pharmaceuticals For: Feb 26 Filed by: NATAN DAVID
Form 4 Cyclacel Pharmaceuticals For: Feb 26 Filed by: Ben-Tzvi Avraham
Form 4 Cyclacel Pharmaceuticals For: Feb 26 Filed by: Lazar David E.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.